Perspective · 18 Jun 2025
Research articlePublished 4 Jan 2021
Incidence of depression in different brain tumor pathologies
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The neuropsychiatric issues in brain cancer patients are reported from the disease process itself or from the cancer therapies. We conducted an epidemiological study to estimate the prevalence of depression in brain tumor patients in different tumor types classified by World Health Organization (WHO). Pakistani brain tumor patients were included in this study as subjects from Jinnah Hospital, Lahore. The depressive symptoms were assessed by examining all patients with the help of a reliable diagnostic questionnaire under the supervision of a neurologist. The results indicated a higher incidence rate (80%) of depression in brain tumor patients. Almost 25% Pituitary adenoma (WHO grade III), 20% Glioblastoma (WHO grade IV), 6% diffused Astrocytoma (WHO grade II), 8% Anaplastic Astrocytoma (WHO grade III), 2% Ependymoma (WHO grade III), 4% Oligodendroglioma (WHO grade II) and 16% Meningioma (WHO grade II/III) brain tumor cases presented depressive illness. We identified high percentage of depression in Pituitary adenoma (WHO grade III) and in Glioblastoma multiform (WHO grade IV) as compared to other tumor pathologies. Neuropsychiatric issues emerging from brain tumors can be mitigated timely if earliest diagnosis is made. Pituitary adenomas often present with the neuropsychiatric symptoms. Depression from Glioblastoma has also been reported. These results are useful in dealing with depression in paients with different brain pathologies. This study encourages oncologists to provide psychological and emotional support to brain tumor patients during treatment and follow-up.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Stroke Research & Therapy.
Perspective · 18 Jun 2025
In ammatory Mechanisms and Neuroin ammation Pathways in Stroke Pathology
Perspective · 18 Jun 2025
Virtual Reality for Post-Stroke Motor Recovery and Its Deficits
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalStroke Research & Therapy
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Saman Shahid”
